Drug Updates
MSHO will periodically provide information about pharmaceutical updates to current therapies. This provides oncologists, hematologists, and professionals in oncology-related fields with relevant information in a timely manner. Included may be a link to the product label, which will provide the relevant clinical information on the indication, contraindications, dosing, and safety. In providing this information, MSHO does not endorse any product or therapy and does not take any position on the safety or efficacy of the product or therapy described.
To view current and resolved drug shortages and discontinuations reported to FDA click here.
Geron's RYTELO™ (imetelstat) Received Permanent J-Code
Effective Janaury 1, 2025
Therapies
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!